Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Tissue Engineering: A New Frontier In Physiological Genomics.
M. C. Petersen, J. Lazar, H. Jacob, T. Wakatsuki
Published 2007 · Biology, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Considerable progress has been made in the last decade in the engineering and construction of a number of artificial tissue types. These constructs are typically viewed from the perspective of possible sources for implant and transplant materials in the clinical arena. However, incorporation of engineered tissues, often referred to as three-dimensional (3D) cell culture, also offers the possibility for significant advancements in research for physiological genomics. These 3D systems more readily mimic the in vivo setting than traditional 2D cell culture, and offer distinct advantages over the in vivo setting for some organ systems. As an example, cardiac cells in 3D culture 1) are more accessible for siRNA studies, 2) can be engineered with specific cell types, and 3) offer the potential for high-throughput screening of gene function. Here the state-of-the-art is reviewed and the applications for engineered tissue in genomics research are proposed. The ability to use engineered tissue in combination with genomics creates a bridge between traditional cellular and in vivo studies that is critical to enabling the transition of genetic information into mechanistic understanding of disease processes.
This paper references
Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology.
F. Wang (1998)
Physiological genomics: tools and concepts
A. Cowley (2004)
Tissue engineered nerve constructs:where do we stand?
C. Chalfoun (2006)
Effects of the controlledreleased basic fibroblast growth factor from chitosangelatin microspheres on human fibroblasts cultured on a chitosangelatin scaffold
H Liu (2003)
Progress and potential for regenerative medicine.
G. Gurtner (2007)
Death in the third dimension: apoptosis regulation and tissue architecture.
N. Zahir (2004)
Effect of scaffold design on bone morphology in vitro.
L. Uebersax (2006)
S100A1 gene transfer: a strategy to strengthen engineered cardiac grafts
A. Remppis (2004)
Intracellular signaling via ERK/MAPK completes the pathway for tubulogenic fibronectin in MDCK cells.
Z. Liu (2007)
Effects of the controlled-released basic fibroblast growth factor from chitosan-gelatin microspheres on human fibroblasts cultured on a chitosan-gelatin scaffold.
H. Liu (2007)
PTEN Regulates Fibroblast Elimination during Collagen Matrix Contraction*
R. Nho (2006)
Reconstitution of the Frank-Starling mechanism in engineered heart tissues.
C. Asnes (2006)
Microarray analysis of gene expression in cultured skin substitutes compared with native human skin.
A. Smiley (2005)
Development of an in vitro pancreatic tissue model to study regulation of islet neogenesis associated protein expression.
M. Petropavlovskaia (2006)
Regulation of the expression of the apolipoprotein(a) gene : Evidence for a regulatory role of the 5' distal ACR enhancer in YAC transgenic mice
T. Huby (2003)
Consomic rat model systems for physiological genomics.
A. Cowley (2004)
In search of a pediatric cardiac surgeon’s ‘Holy Grail’: the ideal pulmonary conduit
N. Solomon (2006)
Stem cells: the next therapeutic frontier.
H. D. Humes (2005)
Gene expression perturbation in vitro--a growing case for three-dimensional (3D) culture systems.
A. Birgersdotter (2005)
Heart muscle engineering: an update on cardiac muscle replacement therapy.
W. Zimmermann (2006)
Optical methods to evaluate the contractile function of unloaded isolated cardiac myocytes.
L. Delbridge (1997)
Mitochondrial membrane potential and reactive oxygen species content of endothelial and smooth muscle cells cultured on poly(epsilon-caprolactone) films.
M. Serrano (2006)
Genetic Polymorphisms of Drug-Metabolising Enzymes and Drug Transporters in the Chemotherapeutic Treatment of Cancer
T. Bosch (2006)
Future of tissue engineering in rheumatic diseases
J. Ringe (2007)
Genomic analysis of smooth muscle cells in 3-dimensional collagen
S Li (2003)
Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies
V.M. Weaver (1997)
Gene therapy used for tissue engineering applications
M. Heyde (2007)
Taking Cell-Matrix Adhesions to the Third Dimension
E. Cukierman (2001)
EXTRACELLULAR MATRIX MODULATES EXPRESSION OF CELL-SURFACE PROTEOGLYCAN GENES IN FIBROBLASTS
沢口 直弘 (2006)
Genomic analysis of smooth muscle cells in three‐dimensional collagen matrix
S. Li (2003)
Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection?
J. E. Baker (2000)
Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling.
L. Freed (2006)
Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype.
J. P. Stegemann (2005)
Optimizing Engineered Heart Tissue for Therapeutic Applications as Surrogate Heart Muscle
Hiroshi Naito (2006)
Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study
S. Ghosh (2005)
Regulation of the Expression of the Apolipoprotein(a) Gene: Evidence for a Regulatory Role of the 5′ Distal Apolipoprotein(a) Transcription Control Region Enhancer in Yeast Artificial Chromosome Transgenic Mice
T. Huby (2003)
Individualized drug therapy.
A. Daly (2007)
Human tissue-engineered blood vessels for adult arterial revascularization
N. L'heureux (2006)
Enhancing the drug metabolism activities of C3A--a human hepatocyte cell line--by tissue engineering within alginate scaffolds.
Tsiona Elkayam (2006)
This paper is referenced by
Electrospun three dimensional scaffolds for bone tissue regeneration
E. Paşcu (2013)
Application of three dimensional (3D) tumor cell culture systems and mechanism of drug resistance.
Adeeb Shehzad (2019)
Quantification by SIFT-MS of acetaldehyde released by lung cells in a 3D model.
A. V. Rutter (2013)
Enhanced cell mitochondrial activity using electrospun nanofibers
V. Jacobs (2015)
A Scaffold-Free Multicellular Three-Dimensional In Vitro Model of Osteogenesis
U. Gurkan (2011)
Engineered Heart Tissue: High Throughput Platform for Dissection of Complex Diseases
J. Lazar (2008)
Biochemistry & Molecular Biology
J. Chambers (2015)
Human-Organoid Models: Accomplishments to Salvage Test-Animals
R. C. Dutta (2016)
Three-Dimensional Systems in Polybutylcyanoacrylate Nanoparticles Safety Evaluation
Glaucia Cristina Mello Santos (2015)
Changes in gene expression during the formation of bioengineered heart muscle.
L. Khait (2009)
Human Dental Pulp Stem Cell Adhesion and Viability Studies in Hybrid Hydrogels
T. Taylor (2014)
3D scaffolds in tissue engineering and regenerative medicine: beyond structural templates?
Tierney G. B. Deluzio (2013)
Morphological and cytoskeletal alterations of nervous system tumor cells with different culturing methods.
Y. Matsuda (2011)
The immunocompromised adult patient and surgery.
K. Littlewood (2008)